We are live on
!
Find out more
BCA
Bray Capital Advisors Portfolio holdings
AUM
$370M
1-Year Est. Return
24.99%
This Fund
S&P 500
This Quarter
Est. Return
-3.59%
1 Year Est. Return
+24.99%
3 Year Est. Return
+36.58%
5 Year Est. Return
+105.92%
10 Year Est. Return
+218.87%
AUM
$389M
AUM Growth
-$19.6M
(-4.8%)
Cap. Flow
+$40.2K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
34.97%
Holding
287
New
8
Increased
56
Reduced
60
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra S&P500
SSO
|
+$2.85M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.6M |
| 3 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$1.01M |
| 4 |
Walt Disney
DIS
|
+$823K |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$483K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$1.1M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$910K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$909K |
| 4 |
NetEase
NTES
|
+$860K |
| 5 |
Alibaba
BABA
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.8% |
| 2 | Healthcare | 8.2% |
| 3 | Financials | 7.95% |
| 4 | Communication Services | 5.89% |
| 5 | Consumer Discretionary | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Crown Castle
CCI
$31.8B
| – | – |
-500
| Closed | -$104K |
|
277
Cognition Therapeutics
CGTX
$95.8M
| – | – |
-250
| Closed | -$2K |
|
|
CRON
278
Cronos Group
CRON
$1.01B
| – | – |
-610
| Closed | -$2K |
|
279
Kyndryl
KD
$3.04B
| – | – |
-10
| Closed | – |
|
280
Roundhill Ball Metaverse ETF
METV
$216M
| – | – |
-745
| Closed | -$11K |
|
281
Amplify Alternative Harvest ETF
MJ
$100M
| $0 | ﹤0.01% |
2
| – | – |
|
|
282
NetEase
NTES
$81.8B
| – | – |
-8,450
| Closed | -$860K |
|
283
iShares S&P 100 ETF
OEF
$20.5B
| – | – |
-95
| Closed | -$21K |
|
284
Organon & Co
OGN
$3.56B
| – | – |
-2
| Closed | – |
|
285
SLB Ltd
SLB
$74.3B
| – | – |
-50
| Closed | -$1K |
|
|
SLNO
286
DELISTED
Soleno Therapeutics
SLNO
| $0 | ﹤0.01% |
133
| – | – |
|
|
RDS.A
287
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-1,950
| Closed | -$85K |
|
Similar funds
ECG
AP
SAM
FWM
WWP
GJCM
CIM
FIM
Bray Capital Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Bray Capital Advisors held 287 positions worth $389M, down 4.8% from $409M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Bray Capital Advisors's Q1 2022 filing shows 8 new, 56 increased, 60 reduced and 11 closed positions. Its largest new stake was ProShares Ultra S&P500: 89,000 shares worth $2.92M. The largest sale was Booking.com, an estimated $1.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- Bray Capital Advisors's largest Q1 2022 buy was ProShares Ultra S&P500: 89,000 shares worth $2.92M.
- Bray Capital Advisors added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q1 2022, an estimated $2.6M increase.
- Bray Capital Advisors's biggest Q1 2022 reduction was Booking.com, cutting an estimated $1.1M.
- Bray Capital Advisors fully exited NetEase in Q1 2022, selling an estimated $860K.
- Bray Capital Advisors's ten largest holdings make up 35% of its $389M portfolio in Q1 2022.
- Bray Capital Advisors opened 8 new positions and closed 11 in Q1 2022.
- Bray Capital Advisors's portfolio value fell 4.8% quarter-over-quarter to $389M.
Based on Bray Capital Advisors's 13F filing for Q1 2022, filed 3 May 2022.